Observational Study of Tocilizumab in Children With Febrile Infection‐Related Epilepsy Syndrome
Early tocilizumab administration may improve outcomes in patients with FIRES, with a clinically acceptable safety profile.
Authors
- Chaonan Fan (ORCID: https://orcid.org/0009-0009-0096-0996)
- Kechun Li (ORCID: https://orcid.org/0000-0003-1611-0450)
- Jun Liu (ORCID: https://orcid.org/0000-0002-7567-0055)
- Zheng Li (ORCID: https://orcid.org/0000-0002-7060-2213)
- Quan Wang (ORCID: https://orcid.org/0000-0002-2821-5017)
- Jie Wu (ORCID: https://orcid.org/0000-0003-4028-6173)
- Yushan He (ORCID: https://orcid.org/0000-0003-3585-8579)
- Suyun Qian
Institutions
- Capital Medical University (CN)
- Beijing Children’s Hospital (CN)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1002/acn3.70120
- Citations
- 4
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- Beijing Municipal Science and Technology Commission